Company / Tangible Book Value per Share
Gilead Sciences Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$11.55
FY2025
5-year range
$8.84 / $11.64
FY2021-FY2025
Trend
+30.6%
vs FY2024
Sector context
#45 of 209
Health Care
What the data says
Gilead Sciences's tangible book value per share of $11.55 is higher than 78% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $7.97 in FY2020 to $14.36 in FY2019.
Based on SEC 10-K filings.
11.55 in FY2025 with a 5-year CAGR of +7.7%. Top quartile in the Health Care sector.
Remained stable around $11.55 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +3.9%
- 5-Year CAGR
- +7.7%
- 10-Year CAGR
- -
Sector benchmark
-87.6% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 30.6% year-over-year.
- Ranks #45 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
- Lowest tangible book value per share in the period was in FY2020.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.55 | +30.6% |
| FY2024 | $8.84 | -24.1% |
| FY2023 | $11.64 | +13.1% |
| FY2022 | $10.29 | -0.4% |
| FY2021 | $10.34 | +29.6% |
| FY2020 | $7.97 | -44.5% |
| FY2019 | $14.36 | +8.8% |
| FY2018 | $13.20 | +6.2% |
| FY2017 | $12.43 | -0.2% |
| FY2016 | $12.46 | +7.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026